Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
1.86M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
56.9K
-
Shares change
-
+56.9K
-
Total reported value, excl. options
-
$187K
-
Value change
-
+$187K
-
Number of buys
-
28
-
Price
-
$3.29
Significant Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (EKSO) as of Q2 2025
28 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.0001 par value per share as of Q2 2025.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (EKSO) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.9K shares
of 1.86M outstanding shares and own 3.05% of the company stock.
Largest 10 shareholders include Cresset Asset Management, LLC (18K shares), GEODE CAPITAL MANAGEMENT, LLC (12.1K shares), VANGUARD GROUP INC (12K shares), BlackRock, Inc. (3.65K shares), FNY Investment Advisers, LLC (3.5K shares), Compagnie Lombard Odier SCmA (1.67K shares), Tower Research Capital LLC (TRC) (1.46K shares), Golden State Wealth Management, LLC (1.3K shares), Roble, Belko & Company, Inc (1.14K shares), and IFP Advisors, Inc (1K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.